Adagene Inc. (NASDAQ:ADAG) and Adicet Bio, Inc. (NASDAQ:ACET): A Comparative Analysis of Market Sentiment
Financial Modeling Prep·2026-01-25 17:00Adagene Inc. (NASDAQ:ADAG) is facing a pessimistic market outlook with a potential downside of 33.08%, indicating cautious investor sentiment towards its monoclonal antibody drugs for cancer treatment.Adicet Bio, Inc. (NASDAQ:ACET) also shows a negative growth potential with a potential downside of 15.29%, despite leading in target price change among peers, reflecting cautious market sentiment towards its gamma delta T cell therapies.The biotechnology sector's inherent risks and uncertainties contribute to ...